Cargando…
A single‐institution pediatric and young adult interventional oncology collaborative: Novel therapeutic options for relapsed/refractory solid tumors
BACKGROUND: Pediatric interventional oncology (PIO) is a growing field intended to provide additional or alternative treatment options for pediatric patients with benign or malignant tumors. Large series of patients treated uniformly and subjected to rigorous endpoints for efficacy are not available...
Autores principales: | Shaikh, Raja, Weil, Brent R., Weldon, Christopher B., Chen, Nan, London, Wendy B., Krush, Morgan, Anderson, Megan, Gebhardt, Mark, Church, Alanna J., DuBois, Steven G., Pikman, Yana, Spidle, Jennifer, Wall, Catherine B., Feraco, Angela, Ullrich, Nicole J., Mack, Jennifer W., Mullen, Elizabeth, Kamihara, Junne, Forrest, Suzanne, Shusterman, Suzanne, Janeway, Katherine A., Alomari, Ahmad, Padua, Horacio, Rodriguez‐Galindo, Carlos, O'Neill, Allison F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315804/ https://www.ncbi.nlm.nih.gov/pubmed/37264747 http://dx.doi.org/10.1002/cam4.6026 |
Ejemplares similares
-
Elucidating dissociation activation energies in host–guest assemblies featuring fast exchange dynamics
por: Shusterman-Krush, Ronit, et al.
Publicado: (2020) -
Precision medicine in pediatric oncology
por: Forrest, Suzanne J., et al.
Publicado: (2018) -
The CDK-Activating Kinase (CAK) Csk1 Is Required for Normal Levels of Homologous Recombination and Resistance to DNA Damage in Fission Yeast
por: Gerber, Hilary B., et al.
Publicado: (2008) -
P410: COMBINING MENIN AND MEK INHIBITION TO TREAT CHILDREN WITH POOR PROGNOSTIC KMT2A-R RAS-MUTANT ACUTE LEUKEMIA
por: Scheidegger, Nastassja, et al.
Publicado: (2023) -
ETV6 fusions from insertions of exons 3-5 in pediatric hematologic malignancies
por: Mueller, Sarah B., et al.
Publicado: (2023)